How does BMRN risk compare to the S&P 500?

Compare Biomarin Pharmaceutical Inc. volatility, beta, and drawdowns against the S&P 500 to assess relative risk.

Is BMRN riskier than the market?

If Biomarin Pharmaceutical Inc. has higher volatility and beta than the market, it carries more systematic risk.

Sharpe ratio compares Biomarin Pharmaceutical Inc. returns to risk. Higher Sharpe indicates better risk-adjusted performance.

Data table placeholder - wire to API in batch 12

How does BMRN risk compare to the S&P 500?: Compare Biomarin Pharmaceutical Inc. volatility, beta, and drawdowns against the S&P 500 to assess relative risk.
Is BMRN riskier than the market?: If Biomarin Pharmaceutical Inc. has higher volatility and beta than the market, it carries more systematic risk.
Does BMRN offer good risk-adjusted returns?: Sharpe ratio compares Biomarin Pharmaceutical Inc. returns to risk. Higher Sharpe indicates better risk-adjusted performance.

Data table placeholder - wire to API in batch 12

How does BMRN risk compare to the S&P 500?: Compare Biomarin Pharmaceutical Inc. volatility, beta, and drawdowns against the S&P 500 to assess relative risk.
Is BMRN riskier than the market?: If Biomarin Pharmaceutical Inc. has higher volatility and beta than the market, it carries more systematic risk.
Does BMRN offer good risk-adjusted returns?: Sharpe ratio compares Biomarin Pharmaceutical Inc. returns to risk. Higher Sharpe indicates better risk-adjusted performance.